Karolina A Rygiel

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules

B. Jakobsen, J. Dukes, J. Harper, 2018, PloS one.

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells

B. Jakobsen, G. Bossi, N. Hassan, 2017, Immunology.